Browse the detailed record of transactions filed by Daugherty Frank Joseph, Directeur Médical. Officer active across 1 companies, notably Greenwich LifeSciences, Inc.. Cumulatively, 5 reports have been recorded. Total volume traded: €103k. The latest transaction was disclosed on 25 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Frank Joseph Daugherty is the Chief Medical Officer at Greenwich LifeSciences, Inc. He is responsible for the medical and clinical aspects of the company, which focuses on developing medical treatments. Frank Joseph Daugherty plays a key role in research and development strategy.